Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,927
Closed -$207K 390
2026
Q1
$207K Buy
+2,927
New +$219K ﹤0.01% 659
2025
Q4
Sell
-2,555
Closed -$210K 713
2025
Q3
$210K Sell
2,555
-312
-11% -$24.6K ﹤0.01% 594
2025
Q2
$231K Buy
+2,867
New +$221K 0.01% 528
2022
Q4
Sell
-2,434
Closed -$148K 823
2022
Q3
$148K Sell
2,434
-257
-10% -$16.4K 0.01% 365
2022
Q2
$169K Sell
2,691
-18
-0.7% -$1.19K 0.01% 336
2022
Q1
$190K Buy
2,709
+133
+5% +$8.99K 0.01% 364
2021
Q4
$161K Buy
2,576
+709
+38% +$44.5K 0.01% 389
2021
Q3
$115K Hold
1,867
﹤0.01% 408
2021
Q2
$112K Sell
1,867
-107
-5% -$6.78K ﹤0.01% 422
2021
Q1
$120K Buy
1,974
+107
+6% +$5.91K 0.01% 357
2020
Q4
$88K Hold
1,867
0.01% 313
2020
Q3
$69K Sell
1,867
-27
-1% -$1.02K 0.01% 319
2020
Q2
$69K Sell
1,894
-120
-6% -$4.18K 0.01% 313
2020
Q1
$61.6K Sell
2,014
-4,434
-69% -$197K 0.01% 322
2019
Q4
$329K Buy
6,448
+197
+3% +$9.51K 0.04% 164
2019
Q3
$295K Buy
+6,251
New +$298K 0.04% 204

Other funds holding MET

Evoke Wealth's MET Position: Q2 2026 in Review

Evoke Wealth sold out of MetLife (MET) in Q2 2026, closing a stake of 2,927 shares — an estimated $207K sold.

Evoke Wealth first reported a position in MET in Q3 2019 and held it in 16 quarters. The position peaked at $329K in Q4 2019. 1,438 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Evoke Wealth reported no remaining MetLife position as of Q2 2026 after selling out during the quarter.
  • Evoke Wealth sold 2,927 MetLife shares in Q2 2026, an estimated $207K.
  • Evoke Wealth first reported a position in MetLife in Q3 2019 and held it in 16 quarters.
  • Evoke Wealth's MetLife position peaked at $329K in Q4 2019.
  • 1,438 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Evoke Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.